3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
23
Breast Neoplasms
12
Prostatic Neoplasms
11
Triple Negative Breast Neoplasms
7
Fallopian Tube Neoplasms
7
Stomach Neoplasms
5
Neoplasm Metastasis
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Fanconi Anemia, Complementation Group D1
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Endometrial Neoplasms
2
Interventions
Octreotide
5
Everolimus
4
pasireotide
3
lanreotide
3
ganitumab
2
gallium Ga 68 dotatate
2
cabozantinib
2
Nivolumab
2
Erlotinib Hydrochloride
2
surufatinib
1
pertuzumab
1
nintedanib
1
ibrutinib
1
fosbretabulin
1
conatumumab
1
cixutumumab
1
carfilzomib
1
arginyllysine
1
aflibercept
1
Temozolomide
1
Sunitinib
1
Somatostatin
1
Random Allocation
1
Ramucirumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Capecitabine
1
Bevacizumab
1
Axitinib
1
(18F)GTP1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoid Tumor
×
olaparib
×
Clear all
No trials found.